OraSure and the National Association of People with AIDS Launch Third Annual ''Mayors Campaign against HIV(TM)'' for National HI
26 Giugno 2007 - 12:00PM
Business Wire
OraSure Technologies, Inc. (NASDAQ:OSUR) and the National
Association of People with AIDS (NAPWA) announced today the launch
of the third annual Mayors Campaign Against HIV�, a national
campaign to encourage testing for HIV and promote the benefits of
knowing one�s HIV status. The Campaign is being sponsored by
OraSure Technologies, the manufacturer of the OraQuick ADVANCE�
Rapid HIV-1/2 Antibody Test, in observance of National HIV Testing
Day (NHTD) on Wednesday, June 27, 2007. NAPWA and OraSure
Technologies have collaborated with city public health departments
and community-based organizations across the country to elicit
mayoral support to urge HIV testing and prevention among their
constituencies. To date, 33 Mayor�s and/or Department of Health
offices in major metropolitan cities nationwide have committed
their participation and support including New York City, San
Francisco, Chicago, Los Angeles, Houston, Seattle, Newark, Phoenix
and Washington, D.C. Several Mayors have also committed to getting
tested on June 27th while others are issuing proclamations or
holding press conferences to encourage individuals to get screened
for HIV. As part of this campaign, OraSure Technologies will be
joined by Frank Oldham, Jr., Executive Director of NAPWA, to
preside over the NASDAQ Stock Market opening on National HIV
Testing Day. This event will spotlight the importance of this
annual observance, as well as the collective support of OraSure,
various governmental agencies, the media and HIV/AIDS organizations
to increase HIV testing and awareness nationwide. Now in its 13th
year, National HIV Testing Day is an annual event led by NAPWA to
encourage the millions of Americans who are at-risk for HIV to
receive voluntary HIV counseling and testing. According to the
Centers for Disease Control and Prevention, approximately 1.1
million individuals in the United States are infected with the HIV
virus, yet more than one-quarter do not know they have the disease.
�We are very pleased to be joining forces with NAPWA and the
participating mayors again this year as we publicly unite in the
fight against HIV/AIDS through our Mayors Campaign Against HIV�,�
said Douglas A. Michels, President and Chief Executive Officer of
OraSure Technologies. �As the only FDA-approved rapid, oral fluid
HIV test in the U.S., the OraQuick ADVANCE� Rapid HIV-1/2 Antibody
Test will help to get more people tested and enable HIV-positive
people to learn their status earlier so they can access care
sooner. We are committed to working in partnership with national,
state and local health agencies to make the OraQuick ADVANCE� test
available to all who need it.� �Each year, National HIV Testing Day
brings together thousands of local health departments, community
organizations and HIV/AIDS advocacy groups nationwide to encourage
early diagnosis and routine testing for HIV/AIDS, and the Mayors
Campaign Against HIV� helps to further support this mission,� said
Frank Oldham, Jr., NAPWA�s executive director. �Education remains
one of the most powerful tools in the fight against HIV/AIDS. By
working in partnership with OraSure and mayors around the country,
we hope to educate thousands nationwide on the need for HIV testing
and prevention. We are thankful for the dedication and support of
both OraSure and each mayoral office participating in the
campaign.� In appreciation of the mayors� involvement in the
Campaign, NAPWA and OraSure Technologies will donate more than
20,000 OraQuick ADVANCE� Rapid HIV-1/2 Antibody Tests to city
health departments and community-based organizations throughout the
country. OraQuick ADVANCE� is the first and only U.S. Food and Drug
Administration approved and CLIA (Clinical Laboratory Improvements
Amendments Act of 1988) waived rapid point-of-care test that can
detect antibodies to both HIV-1 and HIV-2 in 20 minutes, using oral
fluid, finger-stick or venipuncture whole blood or plasma
specimens. About the National Association of People with AIDS
(NAPWA-US) The National Association of People with AIDS (NAPWA-US)
is the oldest national AIDS organization in the United States and
the oldest national network of people living with HIV/AIDS in the
world. Founded in 1983, NAPWA is a non-profit membership
organization that advocates on behalf of all people living with HIV
and AIDS in order to end the pandemic and the human suffering it
causes. NAPWA has several initiatives designed to promote access to
and the utilization of HIV prevention and treatment and reduce
stigma towards HIV-positive people. Nearly one million Americans
are living with HIV and more than 40 million people around the
world are infected. We will be here until there is a cure. More
information on NAPWA and national HIV Testing Day can be found at
http://www.napwa.org. About OraSure Technologies OraSure
Technologies develops, manufactures and markets oral fluid specimen
collection devices using proprietary oral fluid technologies,
diagnostic products including immunoassays and other in vitro
diagnostic tests, and other medical devices. These products are
sold in the United States as well as internationally to various
clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, distributors,
government agencies, physicians' offices, and commercial and
industrial entities. OraSure Technologies is the leading supplier
of oral-fluid collection devices and assays to the life insurance
industry and public health markets for the detection of HIV. In
addition, the Company supplies oral-fluid testing solutions for
drugs of abuse testing. For more information on the Company, please
go to http://www.orasure.com.
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Lug 2023 a Lug 2024